Pembrolizumab plus lenvatinib for all advanced endometrial cancer? Maybe not
- PMID: 35190462
- DOI: 10.1136/ijgc-2022-003419
Pembrolizumab plus lenvatinib for all advanced endometrial cancer? Maybe not
Keywords: endometrial neoplasms.
Conflict of interest statement
Competing interests: EP works as an internal expert for GSK.
Comment on
-
Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer.N Engl J Med. 2022 Feb 3;386(5):437-448. doi: 10.1056/NEJMoa2108330. Epub 2022 Jan 19. N Engl J Med. 2022. PMID: 35045221 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources